Improved blood compatibility of a stent graft by combining heparin coating and abciximab

Thrombosis Research

Volumn 115, Issue 3, 2005, Pages 245-253

  Christensen, Kjeld ^a   Larsson, Rolf ^b   Emanuelsson, Håkan ^c   Elgue, Graciela ^b   Larsson, Anders ^d  

^a ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^b Radiology and Clinical Immunology   (Sweden)

^c ASTRAZENECA R AND D   (Sweden)

^d UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Anticoagulants; Glycoproteins; Monoclonal antibodies; Platelets; Stents

Indexed keywords

ABCIXIMAB; CD11B ANTIGEN; CORLINE; HEPARIN; POLITEF; THROMBIN ANTITHROMBIN COMPLEX;

ARTICLE; BLOOD COMPATIBILITY; BLOOD SAMPLING; COMPLEMENT SYSTEM; CONTROLLED STUDY; CORONARY STENT; CORRELATION ANALYSIS; DRUG COATING; DRUG EFFECT; DRUG POTENTIATION; HEMOCONCENTRATION; HUMAN; INTERMETHOD COMPARISON; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; TUBE;

ANTIBODIES, MONOCLONAL; ANTICOAGULANTS; BLOOD COAGULATION; BLOOD PLATELETS; COATED MATERIALS, BIOCOMPATIBLE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HEPARIN; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; PLATELET ACTIVATION; PLATELET COUNT; POLYTETRAFLUOROETHYLENE; STENTS;

EID: 11144292144     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2004.08.030     Document Type: Article

References (24)

1. C.J. George, D.S. Baim, J.A. Brinker, D.L. Fischman, S. Goldberg, and R. Holubkov One-year follow-up of the Stent Restenosis (STRESS I) Study Am. J. Cardiol. 81 7 1998 860 865
2. P.W. Serruys, B.H. Strauss, K.J. Beatt, M.E. Bertrand, J. Puel, and A.F. Rickards Angiographic follow-up after placement of a self-expanding coronary-artery stent N. Engl. J. Med. 324 1 1991 13 17
3. P.B. Berger, M.R. Bell, C.S. Rihal, H. Ting, G. Barsness, and K. Garratt Clopidogrel versus ticlopidine after intracoronary stent placement J. Am. Coll. Cardiol. 34 7 1999 1891 1894
4. A. Colombo, P. Hall, S. Nakamura, Y. Almagor, L. Maiello, and G. Martini Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance Circulation 91 6 1995 1676 1688
5. F. Kiemeneij, G. Laarman, and T. Slagboom Mode of deployment of coronary Palmaz-Schatz stents after implantation with the stent delivery system: an intravascular ultrasound study Am. Heart J. 129 4 1995 638 644
6. E.J. Topol, J.J. Ferguson, H.F. Weisman, J.E. Tcheng, S.G. Ellis, and N.S. Kleiman Long-term protection from myocardial ischemic events in a randomized trial of brief integrin beta3 blockade with percutaneous coronary intervention. EPIC Investigator Group. Evaluation of Platelet IIb/IIIa Inhibition for Prevention of Ischemic Complication JAMA 278 6 1997 479 484
7. D.J. Kereiakes, A.M. Lincoff, D.P. Miller, J.E. Tcheng, C.F. Cabot, and K.M. Anderson Abciximab therapy and unplanned coronary stent deployment: favorable effects on stent use, clinical outcomes, and bleeding complications. EPILOG Trial Investigators Circulation 97 9 1998 857 864
8. E.J. Topol, D.B. Mark, A.M. Lincoff, E. Cohen, J. Burton, and N. Kleiman Outcomes at 1 year and economic implications of platelet glycoprotein IIb/IIIa blockade in patients undergoing coronary stenting: results from a multicentre randomised trial. EPISTENT Investigators. Evaluation of Platelet IIb/IIIa Inhibitor for Stenting Lancet 354 9195 1999 2019 2024
9. K. Christensen, R. Larsson, H. Emanuelsson, G. Elgue, and A. Larsson Coagulation and complement activation Biomaterials 22 4 2001 349 355
10. T.E. Mollnes, T. Lea, S.S. Froland, and M. Harboe Quantification of the terminal complement complex in human plasma by an enzyme-linked immunosorbent assay based on monoclonal antibodies against a neoantigen of the complex Scand. J. Immunol. 22 2 1985 197 202
11. R.A. Schatz, J.C. Palmaz, F.O. Tio, F. Garcia, O. Garcia, and S.R. Reuter Balloon-expandable intracoronary stents in the adult dog Circulation 76 2 1987 450 457
12. S.P. Karas, M.B. Gravanis, E.C. Santoian, K.A. Robinson, K.A. Anderberg, and S.B. King III Coronary intimal proliferation after balloon injury and stenting in swine: an animal model of restenosis J. Am. Coll. Cardiol. 20 2 1992 467 474
13. H. Hanke, J. Kamenz, S. Hassenstein, M. Oberhoff, K.K. Haase, and A. Baumbach Prolonged proliferative response of smooth muscle cells after experimental intravascular stenting Eur. Heart J. 16 6 1995 785 793
14. V. Fuster, E. Falk, J.T. Fallon, L. Badimon, J.H. Chesebro, and J.J. Badimon The three processes leading to post PTCA restenosis: dependence on the lesion substrate Thromb. Haemost. 74 1 1995 552 559
15. M. Hamon, C. Bauters, E.P. McFadden, N. Wernert, J.M. Lablanche, and B. Dupuis Restenosis after coronary angioplasty Eur. Heart J. 16 Suppl. I 1995 33 48
16. D. Aronson, Z. Bloomgarden, and E.J. Rayfield Potential mechanisms promoting restenosis in diabetic patients J. Am. Coll. Cardiol. 27 3 1996 528 535
17. S.H. Kennedy, S. Rouda, H. Qin, S. Aho, J. Selber, and E.M. Tan Basic FGF regulates interstitial collagenase gene expression in human smooth muscle cells J. Cell. Biochem. 65 1 1997 32 41
18. E. Van Belle, F.O. Tio, D. Chen, L. Maillard, M. Kearney, and J.M. Isner Passivation of metallic stents after arterial gene transfer of phVEGF165 inhibits thrombus formation and intimal thickening J. Am. Coll. Cardiol. 29 6 1997 1371 1379
19. P.A. Hardhammar, H.M. van Beusekom, H.U. Emanuelsson, S.H. Hofma, P.A. Albertsson, and P.D. Verdow Reduction in thrombotic events with heparin-coated Palmaz-Schatz stents in normal porcine coronary arteries Circulation 93 3 1996 423 430
20. P.W. Serruys, H. Emanuelsson, W. van der Giessen, A.C. Lunn, F. Kiemeney, and C. Macaya Heparin-coated Palmaz-Schatz stents in human coronary arteries. Early outcome of the Benestent-II Pilot Study Circulation 93 3 1996 412 422
21. B.S. Coller Binding of abciximab to alpha V beta 3 and activated alpha M beta 2 receptors: with a review of platelet-leukocyte interactions Thromb. Haemost. 82 2 1999 326 336
22. J. Sanchez, G. Elgue, J. Riesenfeld, and P. Olsson Studies of adsorption, activation, and inhibition of factor XII on immobilized heparin Thromb. Res. 89 1 1998 41 50
23. K.N. Ekdahl, G. Elgue, and B. Nilsson Phosphorylation of coagulation factor XI by a casein kinase released by activated human platelets increases its susceptibility to activation by factor XIIa and thrombin Thromb. Haemost. 82 4 1999 1283 1288
24. J.A. Oliver, D.M. Monroe, H.R. Roberts, and M. Hoffman Thrombin activates factor XI on activated platelets in the absence of factor XII Arterioscler. Thromb. Vasc. Biol. 19 1 1999 170 177